surmount-1 tirzepatide weight loss percent nejm 2022 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Tirzepatide vs Semaglutide: Weight Loss

Questions and answers about FDAs initiative against contaminated weight loss products. US Food and Drug Administration website

Pkh1/2-dependent phosphorylation of Vps27 regulates ESCRT-I recruitment to endosomes

11.0 11.1 Van Konynenburg, RA (March 6, 2011)

Individual results vary based on dose, adherence, diet, and physical activity

Disclaimer The information provided in this video is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment

Accessed 16 July 2021 Graveling AJ, Frier BM (2015) Driving and diabetes: problems, licensing restrictions and recommendations for safe driving